Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul J. Catalano, Sc.D.

Co-Author

This page shows the publications co-authored by Paul Catalano and Yolonda Colson.
Connection Strength

0.715
  1. Lung Cancer Strategist Program: A novel care delivery model to improve timeliness of diagnosis and treatment in high-risk patients. Healthc (Amst). 2021 Sep; 9(3):100563.
    View in: PubMed
    Score: 0.236
  2. Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids. J Thorac Cardiovasc Surg. 2015 May; 149(5):1417-24; discussion 1424-25.e1.
    View in: PubMed
    Score: 0.152
  3. Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. Biomaterials. 2013 Feb; 34(7):1810-9.
    View in: PubMed
    Score: 0.131
  4. Cytoreductive surgery and intraoperative administration of paclitaxel-loaded expansile nanoparticles delay tumor recurrence in ovarian carcinoma. Ann Surg Oncol. 2013 May; 20(5):1684-93.
    View in: PubMed
    Score: 0.130
  5. Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Clin Lung Cancer. 2015 Jan; 16(1):24-32.
    View in: PubMed
    Score: 0.037
  6. Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy. Ann Surg Oncol. 2012 Jan; 19(1):199-206.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.